Status:

COMPLETED

Intravoxel Incoherent Motion Prognostic Value in the Initial Evaluation of Patients With Acute Ischemic Strokes Using 3 Tesla Magnetic Resonance Imaging

Lead Sponsor:

Fondation Ophtalmologique Adolphe de Rothschild

Conditions:

Stroke

Magnetic Resonance Imaging

Eligibility:

All Genders

18+ years

Brief Summary

Ischemic strokes are the first cause of handicap in adult people, the second cause of dementia and the third cause of death in France. Brain Magnetic Resonance (MR) initial assessment is mandatory to ...

Eligibility Criteria

Inclusion

  • Adult patients
  • Admitted for an acute ischemic stroke
  • Affiliated to a Social Security scheme

Exclusion

  • Absolute contraindications to MRI
  • Pregnant or breastfeeding woman

Key Trial Info

Start Date :

August 10 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 14 2021

Estimated Enrollment :

274 Patients enrolled

Trial Details

Trial ID

NCT03265860

Start Date

August 10 2017

End Date

June 14 2021

Last Update

July 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fondation Ophtalmologique A. de Rothschild

Paris, France